Longer or shorter dual antiplatelet therapy in dialysis patients receiving a coronary drug-eluting stent? A rope game still ongoing

In this issue of Clinical Kidney Journal, Park et al. presents the results of a nationwide population-based trial that included >5000 dialysis patients receiving a drug-eluting stent (DES). The main objective was to evaluate the effectiveness and the safety of prolonged dual antiplatelet therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Burlacu, Alexandru, Covic, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Editorial Comments
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577774/
https://www.ncbi.nlm.nih.gov/pubmed/33125001
http://dx.doi.org/10.1093/ckj/sfaa040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577774/
https://www.ncbi.nlm.nih.gov/pubmed/33125001
http://dx.doi.org/10.1093/ckj/sfaa040

Ejemplares similares